Digistain gains clinical data to support rapid breast cancer assessment method
Digistain, a company with its roots at Imperial, has proven the worth of its breast cancer assessment method in a significant clinical trial.
Using deep learning to improve rapid cellular imaging
Researchers have combined neural networks with a wide range of microscopy techniques to improve how scientists peer into cells
Research shows how a tiny device in the ear canal can monitor heart health
A driving simulation study has shown we are one step closer to monitoring our heart health in real time via a tiny device worn in the ear.
Psychedelic therapy may help break the chains of gambling addiction
Researchers at Imperial’s Centre for Psychedelic Research are using brain imaging to understand addictions and devise new approaches to treating them.
Prostate cancer focal therapy is cost effective and may improve patient outcomes
Minimally invasive focal therapies for prostate cancer are associated with a lower overall cost and improved quality of life for patients.
New AI tool detects up to 13% more breast cancers than humans alone
A new AI tool from Kheiron Medical Technologies and Imperial College London can detect up to 13% more breast cancers than humans in breast screenings.
New tool to help AI track animals could boost biology research
A new machine learning tool from Imperial could help researchers track animal behaviour and pave the way for more AI use in the biological sciences.
Bendy X-rays and DMT infusions: News from Imperial
Here’s a batch of fresh news and announcements from across Imperial.
Hidden way for us to feel touch uncovered by Imperial researchers
Imperial researchers have discovered a hidden mechanism within hair follicles that allow us to feel touch.
4
Fluorescence gives doctors a real-time connection with the health of the gut
Imperial and US medical technology company MediBeacon have partnered to advance a non-invasive method of assessing intestinal health.
